Invention Grant
US08831891B2 Direct solid sample analytical technology for determining a content and a uniformity thereof in a lyophilized kit of a sulfur-containing chelator with a stable complex capacity for radiotechnetium (Tc-99M) and radiorhenium (Re-186, Re-188)
有权
用于确定具有稳定的放射性核磁共振能力(Tc-99M)和镭(Re-186,Re-188)的含硫螯合剂的冻干试剂盒中的含量和均匀性的直接固体样品分析技术,
- Patent Title: Direct solid sample analytical technology for determining a content and a uniformity thereof in a lyophilized kit of a sulfur-containing chelator with a stable complex capacity for radiotechnetium (Tc-99M) and radiorhenium (Re-186, Re-188)
- Patent Title (中): 用于确定具有稳定的放射性核磁共振能力(Tc-99M)和镭(Re-186,Re-188)的含硫螯合剂的冻干试剂盒中的含量和均匀性的直接固体样品分析技术,
-
Application No.: US13273346Application Date: 2011-10-14
-
Publication No.: US08831891B2Publication Date: 2014-09-09
- Inventor: Kung-Tien Liu , Ming-Yu Chao , Yi-Chih Hsia , Shih-Woei Yeh , Mei-Hsiu Liao , Lee-Chung Men , Lie-Hang Shen
- Applicant: Kung-Tien Liu , Ming-Yu Chao , Yi-Chih Hsia , Shih-Woei Yeh , Mei-Hsiu Liao , Lee-Chung Men , Lie-Hang Shen
- Applicant Address: TW Taoyuan County
- Assignee: Institute of Nuclear Energy Research Atomic Energy Council, Executive Yuan
- Current Assignee: Institute of Nuclear Energy Research Atomic Energy Council, Executive Yuan
- Current Assignee Address: TW Taoyuan County
- Agency: WPAT, PC
- Agent Justin King
- Priority: TW99135930A 20101021
- Main IPC: A61K51/04
- IPC: A61K51/04

Abstract:
The present invention is related to a direct solid sample analytical technology for determining a content and a uniformity thereof in a lyophilized kit of a sulfur-containing chelator with a stable complex capacity for radiotechnetium (Tc-99m) and radiorhenium (Re-186, Re-188). An economical, stable and easily accessible coal standard is used herein as a contrast substance to construct a sulfur calibration curve, followed by obtaining the sulfur content and the uniformity thereof in the solid lyophilized sample by interpolating the foregoing result into the sulfur calibration curve. Then, the weight content percent is converted to get the content and the uniformity of the chelator in the lyophilized kit. The quality control of active pharmaceutical ingredients (API) in the lyophilized kit during key production processes and clinical applications is thus assured.
Public/Granted literature
Information query